Coeptis Therapeutics Holdings, Inc.
Ticker: 1759186
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 0.11-54.2% | 0.24+20.0% | 0.20+233.3% | 0.06 |
| Total Income | 0.11-54.2% | 0.24+20.0% | 0.20+233.3% | 0.06 |
| EXPENSES | ||||
| Expenditure | 4.03+48.7% | 2.71-42.6% | 4.72+14.6% | 4.12 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||
| PBT | -4.02-38.6% | -2.90+33.0% | -4.33-26.6% | -3.42 |
| Net Profit | -4.02-38.6% | -2.90+33.0% | -4.33-26.6% | -3.42 |
| KEY METRICS | ||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.65-12.1% | -0.58+50.4% | -1.17-5.4% | -1.11 |
Corporate Events
Board MeetingCOEP
202622May
Board Meeting
Michelle Burke resigned as Co-Chief Executive Officer and di…
SEC Filing ↗